Ziopharm Oncology reported $68.71M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amgen AMGN:US $ 8217M 30M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
AstraZeneca AZN:LN 39744M 24068M
Baxter International BAX:US $ 8770M 276M
Biogen BIIB:US $ 10429.9M 322M
Bioline Rx BLRX:US $ 70.9M 2.99M
Bristol Myers Squibb BMY:US $ 37213M 405M
Corcept Therapeutics CORT:US $ 540.23M 17.55M
Curis CRIS:US $ 102.91M 9.56M
Eleven Biotherapeutics EBIO:US $ 161.01M 111.66M
Gilead Sciences GILD:US $ 21471M 1768M
GlaxoSmithKline GSK:LN 15426M 49M
Immunogen IMGN:US $ 77.09M 8.63M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
Intrexon XON:US $ 131.25M 27.95M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Novartis NOVN:VX SF 56771M 2729M
Ptc Therapeutics PTCT:US $ 104.93M 91.65M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Tg Therapeutics TGTX:US $ 311.52M 71.61M
Verastem VSTM:US $ 95.66M 7.45M
YTE INCY:US $ 3148.66M 212.8M
Ziopharm Oncology ZIOP:US $ 68.71M 19.57M